Đang chuẩn bị liên kết để tải về tài liệu:
Doxorubicin-induced transcriptome meets interactome: identification of new drug targets

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

The working mechanism of the chemotherapeutic drug doxorubicin, which is frequently used in cancer treatment, its effects on cell metabolism, and pathways activated solely by doxorubicin are not fully known. Understanding these principles is important both in improving existing therapies and in finding new drug targets. Here, I describe a systems-biology approach to find a generalizable working principle for doxorubicin by superimposition of human interactome over gene datasets commonly expressed among various cancer types. |